ACTIVE

ASTEL MEDICA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result470,5 k €-41,1 %over 1 year

Gross margin2,1 M €-33,2 %over 1 year

Equity1,4 M €-0,0 %over 1 year

Workforce14,6 ETP-35,1 %over 1 year

Identity

Source · BCE/KBO

ASTEL MEDICA is a Public limited company incorporated in 2000. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Tinlot. It employs on average 14,6 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0472.890.044
Incorporation: 02/10/2000
Legal form: Public limited company
Registered office: Rue du Zoning 5
4557 Tinlot · WallonieSee on map
Contributed capital: 124 000,00 €
Latest accounts: 31/12/2025
Average workforce: 14,6 ETP

Activities (NACE)

21201Manufacture of pharmaceutical preparations· main 21201Manufacture of pharmaceutical preparations 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 51460Air transport 46460Wholesale of pharmaceutical goods+1

Joint committees (4)

116
11600
207
20700

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 17 financial years

	2025		2024		2022		2021		2018
Income statement
Gross margin	2,1 M €	-33.2%	3,2 M €	+89.7%	1,7 M €	-33.8%	2,5 M €	-35.8%	4 M €
EBITDA	851,1 k €	-37.3%	1,4 M €	+145%	555 k €	-38.2%	897,4 k €	-24.1%	1,2 M €
Operating result	676,1 k €	-40.0%	1,1 M €	+202%	373,2 k €	-47.6%	711,8 k €	-7.5%	769,4 k €
Net result	470,5 k €	-41.1%	798,8 k €	+208%	259,5 k €	-52.6%	548 k €	+2.9%	532,7 k €
Balance sheet
Equity	1,4 M €	-0.0%	1,4 M €	+8.9%	1,3 M €	-0.3%	1,3 M €	-52.5%	2,7 M €
Total assets	2,6 M €	-27.7%	3,7 M €	+28.0%	2,9 M €	-23.1%	3,7 M €	-20.3%	4,7 M €
Cash	228,2 k €	-69.9%	759,2 k €	+75.7%	432,2 k €	+10.4%	391,3 k €	-10.8%	438,5 k €
Debts	1,2 M €	-45.8%	2,2 M €	+45.1%	1,5 M €	-35.9%	2,4 M €	+35.1%	1,8 M €
Other
Workforce	14,6 ETP	-35.1%	22,5 ETP	+49.0%	15,1 ETP	-35.5%	23,4 ETP	-38.6%	38,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 15 ended

Active mandates

Thouria Louhmadi

Director

Active

Ended mandates

Thouria Louhmadi

Director · since 24 décembre 2021

Ended

Stéphanie Ganhy

Director · since 25 avril 2020 · until 25 avril 2026

Ended

Aurélie GANHY

Director · since 01 juillet 2018 · until 30 juin 2024

Ended

Thouria LOUHMADI

Managing director · since 25 juin 2016 · until 30 avril 2022

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/07/2026	17/07/2025	10/07/2024	14/06/2023	13/06/2022	20/05/2021
General meeting	27/06/2026	28/06/2025	28/06/2024	03/06/2023	04/06/2022	27/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	27/06/2026	22/07/2026	French	PDF
Abridged model	31/12/2024	28/06/2025	17/07/2025	French	PDF
Abridged model	31/12/2023	28/06/2024	10/07/2024	French	PDF
Abridged model	31/12/2022	03/06/2023	14/06/2023	French	PDF
Abridged model	31/12/2021	04/06/2022	13/06/2022	French	PDF
Abridged model	31/12/2020	27/04/2021	20/05/2021	French	PDF
Abridged model	31/12/2019	25/04/2020	11/05/2020	French	PDF
Abridged model	31/12/2018	18/05/2019	22/05/2019	French	PDF
Abridged model	31/12/2017	28/04/2018	16/05/2018	French	PDF
Abridged model	31/12/2016	29/04/2017	22/05/2017	French	PDF
Abridged model	31/12/2015	30/04/2016	20/06/2016	French	PDF
Abridged model	31/12/2014	27/06/2015	02/07/2015	French	PDF
Abridged model	31/12/2013	28/06/2014	10/07/2014	French	PDF
Abridged model	31/12/2012	29/06/2013	11/07/2013	French	PDF
Abridged model	31/12/2011	30/06/2012	10/07/2012	French	PDF
Abridged model	31/12/2010	25/06/2011	18/07/2011	French	PDF
Abridged model	31/12/2009	26/06/2010	14/07/2010	French	PDF
Abridged model	31/12/2008	27/06/2009	10/07/2009	French	PDF
Abridged model	31/12/2007	28/06/2008	11/07/2008	French	PDF
Abridged model	31/12/2006	30/06/2007	10/07/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 15 ended

Active mandates

Thouria Louhmadi

Director

Active

Ended mandates

Thouria Louhmadi

Director · since 24 décembre 2021

Ended

Stéphanie Ganhy

Director · since 25 avril 2020 · until 25 avril 2026

Ended

Aurélie GANHY

Director · since 01 juillet 2018 · until 30 juin 2024

Ended

Thouria LOUHMADI

Managing director · since 25 juin 2016 · until 30 avril 2022

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Restructuring11/10/2023
CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring26/06/2023
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Other28/12/2021
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DIVERS - OBJET - ASSEMBLEE GENERALE
PDF
Mandates01/07/2020
DEMISSIONS, NOMINATIONS
PDF
Other21/09/2018
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates23/02/2018
DENOMINATION
PDF
Mandates17/08/2016
DEMISSIONS, NOMINATIONS
PDF
Other22/04/2016
ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025470,5 k €↓
2024
Annual accounts 2024798,8 k €↑
2022
Annual accounts 2022259,5 k €↓
2021
Annual accounts 2021548 k €↑
2018
Annual accounts 2018532,7 k €↑
2017
Annual accounts 2017385,1 k €↓
2017
Name changeASTEL MEDICA
2016
Annual accounts 2016688,5 k €↓
2015
Annual accounts 2015706 k €↑
2014
Annual accounts 2014553,4 k €↑
2013
Annual accounts 2013254,1 k €↓
2013
Name changePHACOBEL
2012
Annual accounts 2012364 k €↑
2011
Annual accounts 2011268,3 k €↑
2010
Annual accounts 2010179,6 k €↓
2009
Annual accounts 2009188,9 k €↑
2008
Annual accounts 2008119,8 k €↓
2007
Annual accounts 2007227,3 k €↑
2006
Annual accounts 2006137,6 k €
2006
Name changeLABORATOIRES PHACOBEL
02/10/2000
IncorporationPublic limited company

ASTEL MEDICA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline